Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients
Clinical trial NCT02308280 · COMPLETED
Trial details
- NCT number
- NCT02308280
- Sponsor
- Maisonneuve-Rosemont Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2018-09-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.